Search Results 81-90 of 16780 for Imiglucerase

  1. MELD (model for end-stage liver disease) score - Doctors & Departments - Mayo Clinic

    Mayo Clinic scientists, doctors and surgeons develop liver transplant insights and innovations that make transplants safer and available for more people. They ...

  2. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

    About this study. The purpose of this study is to establish the effectiveness, safety, and tolerability of remibrutinib (LOU064) 25 mg b.i.d. in adult ...

  3. Obiltoxaximab (intravenous route) - Side effects & uses - Mayo Clinic

    Obiltoxaximab injection is used together with antibiotics to treat inhalational anthrax. It is also used to prevent inhalational anthrax after a person is ...

  4. Dose Response Study of GSK2330672 for the Treatment of Pruritus in Patients With Primary Biliary Cholangitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

    Ixazomib citrate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as lenalidomide ...

  6. Trastuzumab-qyyp (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Trastuzumab-qyyp injection is used together with other cancer medicines (eg, doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel, ...

  7. A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Study to Compare the Effectiveness and Safety of Emixustat Hydrochloride with Placebo to Treat Macular Atrophy Secondary to Stargadt Disease - Mayo Clinic

    The purpose of this study is to determine if emixustat hydrochloride (emixustat) reduces the rate of progression of macular atrophy (MA) compared to placebo in ...

  9. Ulixertinib in People With Histiocytic Neoplasms - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Study Of Lurbinectedin In Combination With Doxorubicin Versus Doxorubicin Alone As First-line Treatment In Participants With Metastatic Leiomyosarcoma - Mayo Clinic

    The purpose of this study is to evaluate whether the combination of lurbinectedin plus doxorubicin given as first line treatment for metastatic leiomyosarcoma ( ...